Company: ARAI
Filing Date: 2025-01-24
Form Type: CORRESP
Source: 0001493152-25-003662
Chunk: 1

Company: Arrive AI Inc.
Filing Date: 2025-01-24
Form: CORRESP
Chunk 1
---
 to clarify     
 that you do not know whether you will be able to achieve such goals.                        |

RESPONSE:The Company has revised its disclosure to address the Staff’s comment.

Patents, page 43

| 5. | We                                                                                                   
 note your amended disclosure in response to prior comment 17, but do not see any amended             
 disclosure regarding the 130+ filed feature claims that is highlighted in the investor presentation. 
 Please advise.                                                                                       |

RESPONSE:The Company has revised its disclosure in consistency with the investor presentation to reflect that these additional business acquisitions and technology developments focused on receiving multiple packages and multiple users. These foundational patents as well as the newly acquired technology listed in the Form S-1 consisted of over 130+ filed featured claims for tracking packages as well as for collecting data from multiple shipping companies and the commercial and residential customers.

Legal Proceedings, page 45

| 6. | We                                                                                            
 note your revised disclosure in response to prior comment 19, including that you did not      
 include the value of the unpaid salary and stock award. However, Item 103 of Regulation S-K   
 requires that you state the relief sought by the plaintiffs. If the plaintiffs quantified     
 the relief they are seeking, please state such amount; if they did not, please state as much. 
 If you do not believe you are required to provide further                                     |

RESPONSE:The Company has revised its disclosure to include that even though plaintiff’s allegations amount to approximately $29 million in total damages, plaintiff’s allegations have no merit, it is not possible at this time to ascertain an exact figure upon the outcome of this litigation through a court’s final decision, or if any damages may be granted at all, in the opinion of the company’s management and litigation counsel, such allegations are unlikely to proceed given the facts presented before the court, such as the breach of the plaintiff’s obligations under the agreement and the termination of the agreement by the Company for cause.

Certain Relationships and Related Person Transactions, page 57

| 7. | We                                                                                           
 note your amended disclosure in response to prior comment 24. Please add a risk factor that  
 addresses the fact that if you materially default in performing any terms of the agreement   
 and do not timely cure to Mr. O’Toole’s satisfaction, Mr. O’Toole may terminate              
 the Exclusive Patent License Agreement, as amended. And that subsequent to the termination   
 of the agreement, you have agreed to not engage in the use, sale, or other commercialization